Zeitschriftenartikel zum Thema „Pulmonary surfactant“
Geben Sie eine Quelle nach APA, MLA, Chicago, Harvard und anderen Zitierweisen an
Machen Sie sich mit Top-50 Zeitschriftenartikel für die Forschung zum Thema "Pulmonary surfactant" bekannt.
Neben jedem Werk im Literaturverzeichnis ist die Option "Zur Bibliographie hinzufügen" verfügbar. Nutzen Sie sie, wird Ihre bibliographische Angabe des gewählten Werkes nach der nötigen Zitierweise (APA, MLA, Harvard, Chicago, Vancouver usw.) automatisch gestaltet.
Sie können auch den vollen Text der wissenschaftlichen Publikation im PDF-Format herunterladen und eine Online-Annotation der Arbeit lesen, wenn die relevanten Parameter in den Metadaten verfügbar sind.
Sehen Sie die Zeitschriftenartikel für verschiedene Spezialgebieten durch und erstellen Sie Ihre Bibliographie auf korrekte Weise.
van Golde, LMG, JJ Batenburg und B. Robertson. „The Pulmonary Surfactant System“. Physiology 9, Nr. 1 (01.02.1994): 13–20. http://dx.doi.org/10.1152/physiologyonline.1994.9.1.13.
Ramanathan, Rangasamy. „Surfactants in the Management of Respiratory Distress Syndrome in Extremely Premature Infants“. Journal of Pediatric Pharmacology and Therapeutics 11, Nr. 3 (01.07.2006): 132–44. http://dx.doi.org/10.5863/1551-6776-11.3.132.
Bernhard, Wolfgang, Andreas Gebert, Gertrud Vieten, Gunnar A. Rau, Jens M. Hohlfeld, Anthony D. Postle und Joachim Freihorst. „Pulmonary surfactant in birds: coping with surface tension in a tubular lung“. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 281, Nr. 1 (01.07.2001): R327—R337. http://dx.doi.org/10.1152/ajpregu.2001.281.1.r327.
PUTMAN, Esther, Lambert A. J. M. CREUWELS, Lambert M. G. van GOLDE und Henk P. HAAGSMAN. „Surface properties, morphology and protein composition of pulmonary surfactant subtypes“. Biochemical Journal 320, Nr. 2 (01.12.1996): 599–605. http://dx.doi.org/10.1042/bj3200599.
Dobbs, L. G. „Pulmonary Surfactant“. Annual Review of Medicine 40, Nr. 1 (Februar 1989): 431–46. http://dx.doi.org/10.1146/annurev.me.40.020189.002243.
Johansson, Jan, Magnus Gustafsson, Marie Palmblad, Shahparak Zaltash, Bengt Robertson und Tore Curstedt. „Pulmonary Surfactant“. BioDrugs 11, Nr. 2 (1999): 71–77. http://dx.doi.org/10.2165/00063030-199911020-00001.
Nguyen, Thuy N., Stephanie M. Cunsolo, Peter Gal und J. Laurence Ransom. „Infasurf and Curosurf: Theoretical and Practical Considerations with New Surfactants“. Journal of Pediatric Pharmacology and Therapeutics 8, Nr. 2 (01.04.2003): 97–114. http://dx.doi.org/10.5863/1551-6776-8.2.97.
Rosenberg, O. A. „Pulmonary Surfactant Preparations and Surfactant Therapy for ARDS in Surgical Intensive Care (a Literature Review)“. Creative surgery and oncology 9, Nr. 1 (25.04.2019): 50–65. http://dx.doi.org/10.24060/2076-3093-2019-9-1-50-65.
Nishijima, Koji, Ken-ichi Shukunami, Hideo Yoshinari, Jin Takahashi, Hideyuki Maeda, Hitoshi Takagi und Fumikazu Kotsuji. „Interactions among pulmonary surfactant, vernix caseosa, and intestinal enterocytes: intra-amniotic administration of fluorescently liposomes to pregnant rabbits“. American Journal of Physiology-Lung Cellular and Molecular Physiology 303, Nr. 3 (01.08.2012): L208—L214. http://dx.doi.org/10.1152/ajplung.00081.2011.
Wright, Jo Rae, und Samuel Hawgood. „Pulmonary Surfactant Metabolism“. Clinics in Chest Medicine 10, Nr. 1 (März 1989): 83–93. http://dx.doi.org/10.1016/s0272-5231(21)00606-7.
Wood, Alastair J. J., und Alan H. Jobe. „Pulmonary Surfactant Therapy“. New England Journal of Medicine 328, Nr. 12 (25.03.1993): 861–68. http://dx.doi.org/10.1056/nejm199303253281208.
LACAZE-MASMONTEIL, THIERRY. „Pulmonary surfactant proteins“. Critical Care Medicine 21, Supplement (September 1993): S376—S378. http://dx.doi.org/10.1097/00003246-199309001-00048.
Kuroki, Y., und D. R. Voelker. „Pulmonary surfactant proteins“. Journal of Biological Chemistry 269, Nr. 42 (Oktober 1994): 25943–46. http://dx.doi.org/10.1016/s0021-9258(18)47138-4.
SHANNON, DANIEL C. „Pulmonary Surfactant System“. Anesthesiology 62, Nr. 2 (01.02.1985): 216. http://dx.doi.org/10.1097/00000542-198502000-00040.
&NA;. „Pulmonary surfactant genetics“. Advances in Anatomic Pathology 5, Nr. 2 (März 1998): 118. http://dx.doi.org/10.1097/00125480-199803000-00023.
Aliouat, EM, R. Escamilla, C. Cariven, C. Vieu, C. Mullet, E. Dei-Cas und MC Prevost. „Surfactant changes during experimental pneumocystosis are related to Pneumocystis development“. European Respiratory Journal 11, Nr. 3 (01.03.1998): 542–47. http://dx.doi.org/10.1183/09031936.98.11030542.
Rahaman, Sk Mehebub, Budhadeb Chowdhury, Animesh Acharjee, Bula Singh und Bidyut Saha. „Surfactant-based therapy against COVID-19: A review“. Tenside Surfactants Detergents 58, Nr. 6 (01.11.2021): 410–15. http://dx.doi.org/10.1515/tsd-2021-2382.
Kobayashi, T., W. Z. Li, K. Tashiro, R. Takahashi, Y. Waseda, K. Yamamoto und Y. Suzuki. „Disparity between tidal and static volumes of immature lungs treated with reconstituted surfactants“. Journal of Applied Physiology 80, Nr. 1 (01.01.1996): 62–68. http://dx.doi.org/10.1152/jappl.1996.80.1.62.
Walther, Frans J., Monik Gupta, Michael M. Lipp, Holly Chan, John Krzewick, Larry M. Gordon und Alan J. Waring. „Aerosol delivery of dry powder synthetic lung surfactant to surfactant-deficient rabbits and preterm lambs on non-invasive respiratory support“. Gates Open Research 3 (14.01.2019): 6. http://dx.doi.org/10.12688/gatesopenres.12899.1.
Walther, Frans J., Monik Gupta, Michael M. Lipp, Holly Chan, John Krzewick, Larry M. Gordon und Alan J. Waring. „Aerosol delivery of dry powder synthetic lung surfactant to surfactant-deficient rabbits and preterm lambs on non-invasive respiratory support“. Gates Open Research 3 (14.03.2019): 6. http://dx.doi.org/10.12688/gatesopenres.12899.2.
Soll, Roger F., und Jerold F. Lucey. „Surfactant Replacement Therapy“. Pediatrics In Review 12, Nr. 9 (01.03.1991): 261–67. http://dx.doi.org/10.1542/pir.12.9.261.
Elssner, Andreas, Gertraud Mazur und Claus Vogelmeier. „Inhibition of factor XIIIa-mediated incorporation of fibronectin into fibrin by pulmonary surfactant“. American Journal of Physiology-Lung Cellular and Molecular Physiology 276, Nr. 4 (01.04.1999): L625—L630. http://dx.doi.org/10.1152/ajplung.1999.276.4.l625.
Sherman, M. P., J. B. D'Ambola, E. E. Aeberhard und C. T. Barrett. „Surfactant therapy of newborn rabbits impairs lung macrophage bactericidal activity“. Journal of Applied Physiology 65, Nr. 1 (01.07.1988): 137–45. http://dx.doi.org/10.1152/jappl.1988.65.1.137.
Kosim, M. Sholeh. „Use of surfactant in neonatal intensive care units“. Paediatrica Indonesiana 45, Nr. 6 (13.10.2016): 233. http://dx.doi.org/10.14238/pi45.6.2005.233-40.
Gemci, Tevfik, Valery Ponyavin, Richard Collins, Timothy E. Corcoran, Suvash C. Saha und Mohammad S. Islam. „CFD Study of Dry Pulmonary Surfactant Aerosols Deposition in Upper 17 Generations of Human Respiratory Tract“. Atmosphere 13, Nr. 5 (02.05.2022): 726. http://dx.doi.org/10.3390/atmos13050726.
Gross, N. J. „Pulmonary surfactant: unanswered questions.“ Thorax 50, Nr. 4 (01.04.1995): 325–27. http://dx.doi.org/10.1136/thx.50.4.325.
Rider, Evelyn. „Metabolism of Pulmonary Surfactant“. Seminars in Respiratory and Critical Care Medicine 16, Nr. 01 (Januar 1995): 17–28. http://dx.doi.org/10.1055/s-2007-1009812.
Caminiti, Stephen P., und Stephen L. Young. „The Pulmonary Surfactant System“. Hospital Practice 26, Nr. 1 (15.01.1990): 87–100. http://dx.doi.org/10.1080/21548331.1991.11704128.
Chroneos, Zissis C., Krishna Midde, Zvjezdana Sever-Chroneos und Chinnaswamy Jagannath. „Pulmonary surfactant and tuberculosis“. Tuberculosis 89 (Dezember 2009): S10—S14. http://dx.doi.org/10.1016/s1472-9792(09)70005-8.
Weaver, Timothy E. „Pulmonary surfactant-associated proteins“. General Pharmacology: The Vascular System 19, Nr. 3 (Januar 1988): 361–68. http://dx.doi.org/10.1016/0306-3623(88)90029-8.
Liu, Lin, und Quanmin Deng. „Profound Effect of Pulmonary Surfactant on the Treatment of Preterm Infants with Respiratory Distress Syndrome“. Contrast Media & Molecular Imaging 2022 (03.10.2022): 1–10. http://dx.doi.org/10.1155/2022/4166994.
Wright, J. R. „Clearance and recycling of pulmonary surfactant“. American Journal of Physiology-Lung Cellular and Molecular Physiology 259, Nr. 2 (01.08.1990): L1—L12. http://dx.doi.org/10.1152/ajplung.1990.259.2.l1.
Seeger, W., C. Grube, A. Gunther und R. Schmidt. „Surfactant inhibition by plasma proteins: differential sensitivity of various surfactant preparations“. European Respiratory Journal 6, Nr. 7 (01.07.1993): 971–77. http://dx.doi.org/10.1183/09031936.93.06070971.
Homer, Robert J., Tao Zheng, Geoff Chupp, Susan He, Zhou Zhu, Quingshen Chen, Bing Ma et al. „Pulmonary type II cell hypertrophy and pulmonary lipoproteinosis are features of chronic IL-13 exposure“. American Journal of Physiology-Lung Cellular and Molecular Physiology 283, Nr. 1 (01.07.2002): L52—L59. http://dx.doi.org/10.1152/ajplung.00438.2001.
Rider, E. D., A. H. Jobe, M. Ikegami und B. Sun. „Different ventilation strategies alter surfactant responses in preterm rabbits“. Journal of Applied Physiology 73, Nr. 5 (01.11.1992): 2089–96. http://dx.doi.org/10.1152/jappl.1992.73.5.2089.
Milad, Nadia, und Mathieu C. Morissette. „Revisiting the role of pulmonary surfactant in chronic inflammatory lung diseases and environmental exposure“. European Respiratory Review 30, Nr. 162 (15.12.2021): 210077. http://dx.doi.org/10.1183/16000617.0077-2021.
Orgeig, Sandra, Allan W. Smits, Christopher B. Daniels und Jay K. Herman. „Surfactant regulates pulmonary fluid balance in reptiles“. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 273, Nr. 6 (01.12.1997): R2013—R2021. http://dx.doi.org/10.1152/ajpregu.1997.273.6.r2013.
Notter, Robert H., Rohun Gupta, Adrian L. Schwan, Zhengdong Wang, Mohanad Gh Shkoor und Frans J. Walther. „Synthetic lung surfactants containing SP-B and SP-C peptides plus novel phospholipase-resistant lipids or glycerophospholipids“. PeerJ 4 (27.10.2016): e2635. http://dx.doi.org/10.7717/peerj.2635.
Erokhin, V. V., L. N. Lepekha, M. V. Erokhina, I. V. Bocharova, A. V. Kurynina und G. E. Onishchenko. „SELECTIVE EFFECTS OF PULMONARY SURFACTANT ON VARIOUS SUBPOPULATIONS OF ALVEOLAR MACROPHAGES IN THE MODEL OF EXPERIMENTAL TUBERCULOSIS“. Annals of the Russian academy of medical sciences 67, Nr. 11 (10.11.2012): 22–28. http://dx.doi.org/10.15690/vramn.v67i11.467.
Ballard, Philip L., Jeffrey D. Merrill, Rodolfo I. Godinez, Marye H. Godinez, William E. Truog und Roberta A. Ballard. „Surfactant Protein Profile of Pulmonary Surfactant in Premature Infants“. American Journal of Respiratory and Critical Care Medicine 168, Nr. 9 (November 2003): 1123–28. http://dx.doi.org/10.1164/rccm.200304-479oc.
Beers, Michael F., Aaron Hamvas, Michael A. Moxley, Linda W. Gonzales, Susan H. Guttentag, Kola O. Solarin, William J. Longmore, Lawrence M. Nogee und Philip L. Ballard. „Pulmonary Surfactant Metabolism in Infants Lacking Surfactant Protein B“. American Journal of Respiratory Cell and Molecular Biology 22, Nr. 3 (März 2000): 380–91. http://dx.doi.org/10.1165/ajrcmb.22.3.3645.
Whitsett, Jeffrey A. „Review: The intersection of surfactant homeostasis and innate host defense of the lung: lessons from newborn infants“. Innate Immunity 16, Nr. 3 (29.03.2010): 138–42. http://dx.doi.org/10.1177/1753425910366879.
Horowitz, A. D., K. Kurak, B. Moussavian, J. A. Whitsett, S. E. Wert, W. M. Hull, J. McNanie und M. Ikegami. „Preferential uptake of small-aggregate fraction of pulmonary surfactant in vitro“. American Journal of Physiology-Lung Cellular and Molecular Physiology 273, Nr. 2 (01.08.1997): L468—L477. http://dx.doi.org/10.1152/ajplung.1997.273.2.l468.
Graham, Emma, Lynda McCaig, Gloria Shui-Kei Lau, Akash Tejura, Anne Cao, Yi Y. Zuo und Ruud Veldhuizen. „E-cigarette aerosol exposure of pulmonary surfactant impairs its surface tension reducing function“. PLOS ONE 17, Nr. 11 (09.11.2022): e0272475. http://dx.doi.org/10.1371/journal.pone.0272475.
Fisher, James H., Vladimir Sheftelyevich, Ye-Shih Ho, Suzanne Fligiel, Francis X. McCormack, Thomas R. Korfhagen, Jeffrey A. Whitsett und Machiko Ikegami. „Pulmonary-specific expression of SP-D corrects pulmonary lipid accumulation in SP-D gene-targeted mice“. American Journal of Physiology-Lung Cellular and Molecular Physiology 278, Nr. 2 (01.02.2000): L365—L373. http://dx.doi.org/10.1152/ajplung.2000.278.2.l365.
Picone, Anthony, Louis A. Gatto, Gary F. Nieman, Andrew M. Paskanik und Charles Lutz. „PULMONARY SURFACTANT FUNCTION FOLLOWING ENDOTOXIN“. Shock 5, Nr. 4 (April 1996): 304–10. http://dx.doi.org/10.1097/00024382-199604000-00012.
Bisetti, A. „Pulmonary Surfactant and Respiratory Infections“. Respiration 55, Nr. 1 (1989): 45–48. http://dx.doi.org/10.1159/000195750.
BALLARD, PHILIP L. „Hormonal Regulation of Pulmonary Surfactant“. Endocrine Reviews 10, Nr. 2 (Mai 1989): 165–81. http://dx.doi.org/10.1210/edrv-10-2-165.
Whitsett, Jeffrey A., Susan E. Wert und Timothy E. Weaver. „Diseases of Pulmonary Surfactant Homeostasis“. Annual Review of Pathology: Mechanisms of Disease 10, Nr. 1 (24.01.2015): 371–93. http://dx.doi.org/10.1146/annurev-pathol-012513-104644.
Chroneos, Zissis, Zvjezdana Sever-Chroneos und Virginia Shepherd. „Pulmonary Surfactant: An Immunological Perspective“. Cellular Physiology and Biochemistry 25, Nr. 001 (2010): 013–26. http://dx.doi.org/10.1159/000272047.